Welcome to LookChem.com Sign In|Join Free
  • or
1,1-dimethylethyl 4-[(4-bromo-3-fluorophenyl)oxy]-1-piperidinecarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

684249-70-5

Post Buying Request

684249-70-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

684249-70-5 Usage

Chemical class

Piperidinecarboxylates

Structure

Contains a piperidine ring with a carboxylate group

Substituent

4-[(4-bromo-3-fluorophenyl)oxy] at the 1-position

Application

Medicinal chemistry and drug development

Pharmacological properties

Potential for biological activity modulation

Role of 4-[(4-bromo-3-fluorophenyl)oxy] group

Modulation of compound's biological activity

Research value

Valuable for further research in pharmaceutical drug development

Check Digit Verification of cas no

The CAS Registry Mumber 684249-70-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,4,2,4 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 684249-70:
(8*6)+(7*8)+(6*4)+(5*2)+(4*4)+(3*9)+(2*7)+(1*0)=195
195 % 10 = 5
So 684249-70-5 is a valid CAS Registry Number.

684249-70-5Relevant academic research and scientific papers

Regioselective SNAr reactions of substituted difluorobenzene derivatives: practical synthesis of fluoroaryl ethers and substituted resorcinols

Ouellet, Stéphane G.,Bernardi, Anna,Angelaud, Remy,O'Shea, Paul D.

supporting information; experimental part, p. 3776 - 3779 (2009/10/11)

In this Letter, we describe a practical and highly selective method for the preparation of fluoroaryl ethers and differentially substituted resorcinol derivatives. This synthetic strategy relies on a selective SNAr of substituted difluorobenzen

SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS

-

Page 98, (2008/06/13)

The present invention relates to novel piperazine and azepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurodegenerative disorders including Alzheimer's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 684249-70-5